A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150

2006157 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of Oncology

Volume 18, Issue 1, pp. 116-121

Field-Weighted Citation Impact: 8.39